SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Walter Morton who wrote (1820)12/9/1998 7:00:00 PM
From: Steve Harmon  Read Replies (1) | Respond to of 2742
 
If CIST's management would have taken IMNX stock instead of cash>>> Cistron could have closed house today and paid Cistron shareholders a $7 a share dividend.

Cistron shareholders would have made a 28 bagger...



To: Walter Morton who wrote (1820)12/9/1998 8:14:00 PM
From: Steve Harmon  Respond to of 2742
 
Cistron's managers will vote for the "3 more years" plan very quickly.

Maybe by then Cistron will have 5 investment bankers to "enhance" shareholder value...



To: Walter Morton who wrote (1820)12/9/1998 8:22:00 PM
From: Steve Harmon  Respond to of 2742
 
The "cash is king" argument has been blown out of the water at Cistron.

See POST #1460.



HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News